How BerGenBio became a frontrunner in UK hunt for Covid-19 treatment
Bemcentinib has previously been trialled in treating acute myeloid leukaemia (AML), melanoma and other aggressive cancers (Credit: BerGenBio)
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more
